Michael Y Chen1, Ariela R Orkaby2,3, Michael A Rosenberg4,5, Jane A Driver6,7. 1. SUNY Downstate, Brooklyn, NY, USA. 2. New England Geriatric Research, Education, and Clinical Center (GRECC), VA Boston Healthcare System, 150 South Huntington St, Boston, MA, 02130, USA. aorkaby@bwh.harvard.edu. 3. Division of Aging, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA. aorkaby@bwh.harvard.edu. 4. Division of Biomedical Informatics and Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA. 5. Division of Cardiac Electrophysiology, University of Colorado School of Medicine, Aurora, CO, USA. 6. New England Geriatric Research, Education, and Clinical Center (GRECC), VA Boston Healthcare System, 150 South Huntington St, Boston, MA, 02130, USA. 7. Division of Aging, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Evidence for the benefit of implantable cardioverter defibrillators (ICD) in preventing sudden cardiac death (SCD) in older adults is mixed; age alone may not predict benefit. Frailty may help identify patients in whom an ICD does not improve overall mortality risk. METHODS: Structured search of PubMed, Embase, Web of Science, and Cochrane Central Register of Controlled Trials on 1/31/2019, without language restriction, with terms for ICD, frailty, and mortality. Frailty was defined broadly using any validated single component (e.g., walking speed, weight loss) or multi-component tool (e.g., cumulative deficit index). Each study was assessed for quality and risk of bias. RESULTS: We identified and screened 2649 titles, reviewed 280 abstracts, and extracted 71 articles. Nine articles, including two RCTs, one prospective cohort, and six retrospective cohort studies met all criteria. The most common reason for exclusion was a lack of frailty definition. Frailty definitions were heterogeneous, including cumulative deficit models, low weight, and walking speed. Follow-up time for mortality differed: from days to > 6 years. All studies indicated that mortality was higher amongst individuals identified as frail, regardless of definition. In one RCT, slow walkers did not benefit from ICD therapy after 3 years. A cohort of 83,792 Medicare beneficiaries in an ICD registry reported higher 1-year mortality following ICD in those with frailty or dementia. Four studies reported an association between being underweight and increased mortality following ICD placement. CONCLUSION: Existing literature suggests that individuals with frailty may not benefit from ICD placement for primary prevention of SCD.
BACKGROUND: Evidence for the benefit of implantable cardioverter defibrillators (ICD) in preventing sudden cardiac death (SCD) in older adults is mixed; age alone may not predict benefit. Frailty may help identify patients in whom an ICD does not improve overall mortality risk. METHODS: Structured search of PubMed, Embase, Web of Science, and Cochrane Central Register of Controlled Trials on 1/31/2019, without language restriction, with terms for ICD, frailty, and mortality. Frailty was defined broadly using any validated single component (e.g., walking speed, weight loss) or multi-component tool (e.g., cumulative deficit index). Each study was assessed for quality and risk of bias. RESULTS: We identified and screened 2649 titles, reviewed 280 abstracts, and extracted 71 articles. Nine articles, including two RCTs, one prospective cohort, and six retrospective cohort studies met all criteria. The most common reason for exclusion was a lack of frailty definition. Frailty definitions were heterogeneous, including cumulative deficit models, low weight, and walking speed. Follow-up time for mortality differed: from days to > 6 years. All studies indicated that mortality was higher amongst individuals identified as frail, regardless of definition. In one RCT, slow walkers did not benefit from ICD therapy after 3 years. A cohort of 83,792 Medicare beneficiaries in an ICD registry reported higher 1-year mortality following ICD in those with frailty or dementia. Four studies reported an association between being underweight and increased mortality following ICD placement. CONCLUSION: Existing literature suggests that individuals with frailty may not benefit from ICD placement for primary prevention of SCD.
Entities:
Keywords:
frailty; implantable cardioverter defibrillator; sudden cardiac death
Authors: Sari Stenholm; Tamara B Harris; Taina Rantanen; Marjolein Visser; Stephen B Kritchevsky; Luigi Ferrucci Journal: Curr Opin Clin Nutr Metab Care Date: 2008-11 Impact factor: 4.294
Authors: Daniel B Kramer; Susan L Mitchell; Joao Monteiro; Paul W Jones; Sharon-Lise Normand; David L Hayes; Matthew R Reynolds Journal: J Am Heart Assoc Date: 2015-05-15 Impact factor: 5.501
Authors: Jonathan C Hsu; Paul D Varosy; Haikun Bao; Yongfei Wang; Jeptha P Curtis; Gregory M Marcus Journal: J Am Heart Assoc Date: 2012-12-19 Impact factor: 5.501
Authors: Parag Goyal; Eiran Z Gorodeski; Kelsey M Flint; Deena S Goldwater; John A Dodson; Jonathan Afilalo; Mathew S Maurer; Michael W Rich; Karen P Alexander; Scott L Hummel Journal: J Am Geriatr Soc Date: 2019-10-18 Impact factor: 5.562
Authors: Marta Wleklik; Quin Denfeld; Magdalena Lisiak; Michał Czapla; Marta Kałużna-Oleksy; Izabella Uchmanowicz Journal: Int J Environ Res Public Health Date: 2022-02-16 Impact factor: 3.390
Authors: Agnieszka Mlynarska; Rafal Mlynarski; Izabella Uchmanowicz; Czeslaw Marcisz; Krzysztof S Golba Journal: Int J Environ Res Public Health Date: 2020-03-17 Impact factor: 3.390